Jördis J. Ott

6.4k total citations · 2 hit papers
35 papers, 4.6k citations indexed

About

Jördis J. Ott is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jördis J. Ott has authored 35 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in Jördis J. Ott's work include Hepatitis B Virus Studies (11 papers), Hepatitis Viruses Studies and Epidemiology (10 papers) and Viral gastroenteritis research and epidemiology (6 papers). Jördis J. Ott is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Hepatitis Viruses Studies and Epidemiology (10 papers) and Viral gastroenteritis research and epidemiology (6 papers). Jördis J. Ott collaborates with scholars based in Germany, Switzerland and United States. Jördis J. Ott's co-authors include Gérard Krause, Rafael Mikolajczyk, Johannes Horn, Steven Wiersma, Aparna Schweitzer, Gretchen A Stevens, Justina Groeger, Daniel Shouval, Stanley M. Lemon and Pierre Van Damme and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jördis J. Ott

32 papers receiving 4.6k citations

Hit Papers

Estimations of worldwide prevalence of chronic hepatitis ... 2012 2026 2016 2021 2015 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
    2015 2.0k citations Aparna Schweitzer, Johannes Horn et al. The Lancet profile →
  2. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
    2012 1.4k citations Jördis J. Ott, Gretchen A Stevens et al. Vaccine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jördis J. Ott Germany 19 3.8k 3.3k 716 281 268 35 4.6k
Tommaso Stroffolini Italy 37 4.2k 1.1× 4.0k 1.2× 688 1.0× 297 1.1× 198 0.7× 162 5.5k
Deanna Kruszon-Moran United States 20 3.1k 0.8× 2.6k 0.8× 584 0.8× 129 0.5× 113 0.4× 29 4.3k
Daniel Lavanchy Switzerland 27 5.8k 1.5× 5.7k 1.7× 799 1.1× 169 0.6× 176 0.7× 66 7.1k
Maria Elena Tosti Italy 33 1.7k 0.5× 1.7k 0.5× 652 0.9× 189 0.7× 266 1.0× 125 2.9k
Colin W. Shepard United States 25 3.4k 0.9× 2.6k 0.8× 1.2k 1.7× 171 0.6× 84 0.3× 58 4.5k
Lu‐Yu Hwang United States 29 3.8k 1.0× 3.1k 0.9× 598 0.8× 252 0.9× 614 2.3× 64 5.3k
Steven Wiersma United States 20 3.8k 1.0× 4.2k 1.3× 1.6k 2.3× 166 0.6× 142 0.5× 37 5.6k
Noele P. Nelson United States 31 2.8k 0.7× 1.9k 0.6× 683 1.0× 728 2.6× 76 0.3× 88 3.6k
Vana Sypsa Greece 32 2.1k 0.6× 1.0k 0.3× 1.2k 1.7× 144 0.5× 179 0.7× 132 3.4k
M J Alter United States 25 4.6k 1.2× 5.1k 1.5× 796 1.1× 90 0.3× 109 0.4× 55 6.1k

Countries citing papers authored by Jördis J. Ott

Since Specialization
Citations

This map shows the geographic impact of Jördis J. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jördis J. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jördis J. Ott more than expected).

Fields of papers citing papers by Jördis J. Ott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jördis J. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jördis J. Ott. The network helps show where Jördis J. Ott may publish in the future.

Co-authorship network of co-authors of Jördis J. Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Jördis J. Ott. A scholar is included among the top collaborators of Jördis J. Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jördis J. Ott. Jördis J. Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortmann, Jana, et al.. (2025). Feasibility of blood self-sampling with HemaSpot HF for Anti-Clostridium tetani Toxin IgG detection. Scientific Reports. 15(1). 23693–23693.
2.
Nsanzimana, Sabin, et al.. (2022). Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting. BMC Infectious Diseases. 22(1). 500–500. 2 indexed citations
3.
Ott, Jördis J., et al.. (2022). Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis. PLoS ONE. 17(6). e0269253–e0269253. 16 indexed citations
4.
5.
Krause, Gérard, et al.. (2021). Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study. JMIR mhealth and uhealth. 9(5). e26289–e26289. 3 indexed citations
6.
Ott, Jördis J., et al.. (2018). Sex- and age patterns in incidence of infectious diseases in Germany: analyses of surveillance records over a 13-year period (2001–2013). Epidemiology and Infection. 146(3). 372–378. 17 indexed citations
7.
Horn, Johannes, et al.. (2018). Epidemiologic estimates of hepatitis E virus infection in European countries. Journal of Infection. 77(6). 544–552. 10 indexed citations
8.
Lemon, Stanley M., Jördis J. Ott, Pierre Van Damme, & Daniel Shouval. (2017). Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. Journal of Hepatology. 68(1). 167–184. 200 indexed citations
9.
Schweitzer, Aparna, Johannes Horn, Rafael Mikolajczyk, Gérard Krause, & Jördis J. Ott. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet. 386(10003). 1546–1555. 2008 indexed citations breakdown →
10.
11.
Rübsamen, Nicole, Stefanie Castell, Johannes Horn, et al.. (2015). Ebola Risk Perception in Germany, 2014. Emerging infectious diseases. 21(6). 1012–1018. 45 indexed citations
12.
Winkler, Volker, Jördis J. Ott, Melanie Cowan, & Heiko Becher. (2013). Smoking prevalence and its impacts on lung cancer mortality in Sub-Saharan Africa: An epidemiological study. Preventive Medicine. 57(5). 634–640. 15 indexed citations
13.
Ott, Jördis J. & Steven Wiersma. (2013). Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. International Journal of Infectious Diseases. 17(11). e939–e944. 52 indexed citations
14.
Ott, Jördis J., Gretchen A Stevens, & Steven Wiersma. (2012). The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infectious Diseases. 12(1). 131–131. 97 indexed citations
15.
Ott, Jördis J., Greg Irving, & Steven Wiersma. (2012). Long-term protective effects of hepatitis A vaccines. A systematic review. Vaccine. 31(1). 3–11. 68 indexed citations
16.
Ott, Jördis J., Gretchen A Stevens, Justina Groeger, & Steven Wiersma. (2012). Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 30(12). 2212–2219. 1396 indexed citations breakdown →
17.
18.
Winkler, Volker, Jördis J. Ott, Bernd Holleczek, Christa Stegmaier, & Heiko Becher. (2009). Cancer profile of migrants from the Former Soviet Union in Germany: incidence and mortality. Cancer Causes & Control. 20(10). 1873–1879. 22 indexed citations
19.
Winkler, Volker, Jördis J. Ott, & Heiko Becher. (2009). Reliability of coding causes of death with ICD-10 in Germany. Sozial- und Präventivmedizin. 55(1). 43–48. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tommaso Stroffolini Breakdown of academic impact, for papers by Deanna Kruszon-Moran Breakdown of academic impact, for papers by Daniel Lavanchy Breakdown of academic impact, for papers by Maria Elena Tosti Breakdown of academic impact, for papers by Colin W. Shepard Breakdown of academic impact, for papers by Lu‐Yu Hwang Breakdown of academic impact, for papers by Steven Wiersma Breakdown of academic impact, for papers by Noele P. Nelson Breakdown of academic impact, for papers by Vana Sypsa Breakdown of academic impact, for papers by M J Alter
Rankless by CCL
2026